Saturday 17 October 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
1,006.92
8.28
+0.83%
Follow MCK
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 5 | 7 | 7 | 4 | 7 | 7 | 6 | 4 |
P/E ratio |
22.40 | 25.92 | 23.81 | 14.13 | 41.94 | 0.00 | 26.06 | 1,485.50 | 607.87 | 6.29 |
Altman Z-Score |
6.15 | 5.88 | 5.63 | 5.35 | 4.86 | 3.90 | 4.46 | 4.22 | 4.15 | 4.37 |
P/S ratio |
0.27 | 0.24 | 0.23 | 0.18 | 0.18 | 0.13 | 0.11 | 0.11 | 0.14 | 0.17 |
Altman Z″-Score (non-manufacturers) |
0.59 | 0.61 | 0.66 | 0.71 | 0.42 | 0.02 | 1.02 | 1.04 | 1.04 | 1.87 |
P/FCF ratio |
19.77 | 16.41 | 19.70 | 10.92 | 11.96 | 8.03 | 6.32 | 6.71 | 7.72 | 7.83 |
P/Operating CF |
31.27 | 11.07 | 17.23 | 15.11 | 16.15 | 9.29 | 5.25 | 5.99 | 9.62 | 22.83 |
Beneish M-Score |
(2.34) | (2.42) | (2.42) | (2.38) | (2.78) | (3.19) | (2.60) | (2.81) | (2.86) | (2.29) |
Dividend Safety Score |
86 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 178.99 | 4.60 | 2.82 | 2.89 | 2.91 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.28 | 0.25 | 0.25 | 0.21 | 0.21 | 0.17 | 0.12 | 0.13 | 0.16 | 0.19 |
EV/EBITDA |
16.51 | 18.05 | 17.30 | 11.58 | 20.08 | 0.00 | 7.83 | 7.14 | 8.72 | 4.63 |
EV/Operating CF |
18.62 | 15.00 | 18.22 | 11.20 | 12.67 | 8.86 | 6.36 | 6.92 | 7.89 | 8.12 |
EV/FCF |
21.18 | 17.47 | 21.68 | 12.56 | 14.41 | 10.32 | 7.19 | 8.03 | 9.11 | 9.21 |
Quick Ratio |
0.48 | 0.51 | 0.50 | 0.50 | 0.46 | 0.58 | 0.56 | 0.56 | 0.56 | 0.59 |
Current Ratio |
0.85 | 0.90 | 0.92 | 0.92 | 0.95 | 1.03 | 0.99 | 1.02 | 1.01 | 1.04 |
Net Debt/EBITDA |
1.10 | 1.10 | 1.58 | 1.51 | 3.42 | (2.29) | 0.95 | 1.18 | 1.33 | 0.69 |
Debt/Assets |
14.11% | 14.98% | 17.41% | 19.61% | 20.69% | 23.40% | 12.06% | 12.73% | 13.05% | 14.02% |
Debt/Equity |
(6.54) | (6.64) | (7.34) | (8.20) | (7.31) | 86.94 | 1.39 | 0.92 | 0.78 | 0.76 |
Asset Turnover |
5.12 | 5.04 | 4.76 | 4.41 | 4.11 | 3.77 | 3.82 | 3.57 | 3.43 | 3.38 |
Operating CF/Net income |
1.29 | 1.85 | 1.44 | 1.45 | 3.98 | (1.00) | 4.86 | 118.71 | 64.85 | 0.94 |
Capex/Depreciation |
(1.02) | (1.35) | (1.08) | (0.92) | (0.70) | (0.57) | (0.48) | (0.18) | (0.18) | (0.47) |
Interest Coverage |
25.15 | 16.69 | 15.51 | 17.67 | 11.45 | (23.23) | 10.00 | 3.36 | 2.69 | 23.12 |
| (274.39%) | (200.12%) | (194.37%) | (216.94%) | (137.79%) | (165.54%) | 13.24% | 0.37% | 0.63% | 50.00% | |
| 6.05% | 4.62% | 4.63% | 5.67% | 1.74% | (7.19%) | 1.49% | 0.06% | 0.11% | 8.63% | |
ROIC |
66.20% | 71.41% | 43.94% | 45.25% | 16.38% | (34.57%) | 17.92% | 4.29% | 3.12% | 26.13% |
Return on Tangible Assets |
(66.70%) | (88.96%) | (144.95%) | (239.25%) | (779.02%) | (117.59%) | 45.85% | 1.00% | 2.30% | 139.75% |
Average Days of Receivables |
25.32 | 26.07 | 25.54 | 25.60 | 25.70 | 29.39 | 31.52 | 31.07 | 31.03 | 33.49 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% | 0.17% |
Selling, General and Administrative Expense of Revenue |
2.01% | 2.37% | 2.80% | 2.81% | 3.99% | 3.71% | 3.97% | 3.94% | 3.91% | 3.75% |
Intangible Assets out of Total Assets |
0.19 | 0.15 | 0.18 | 0.20 | 0.18 | 0.19 | 0.20 | 0.22 | 0.25 | 0.23 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.25) | (0.25) | (0.29) | (0.39) | (0.40) | (0.62) | (0.56) | (0.55) | (0.45) | (0.39) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 58.59 | 8.72 | 15.82 | 164.44 |
Earnings Yield |
4.47% | 3.86% | 4.20% | 7.07% | 2.38% | (14.63%) | 3.84% | 0.07% | 0.16% | 15.89% |
Free Cash Flow Yield |
5.06% | 6.10% | 5.08% | 9.16% | 8.36% | 12.45% | 15.83% | 14.91% | 12.95% | 12.76% |
Revenue per Share |
3,264.00 | 2,818.30 | 2,319.45 | 1,961.10 | 1,733.20 | 1,483.36 | 1,279.35 | 1,091.79 | 1,001.72 | 898.34 |
Operating CF per Share |
49.80 | 47.76 | 32.39 | 36.56 | 29.11 | 28.28 | 24.22 | 20.56 | 20.89 | 21.47 |
Capex per Share |
(6.03) | (6.74) | (5.16) | (3.95) | (3.51) | (3.99) | (2.80) | (2.84) | (2.79) | (2.54) |
Free Cash Flow per Share |
43.77 | 41.02 | 27.23 | 32.61 | 25.60 | 24.29 | 21.42 | 17.72 | 18.10 | 18.92 |
Cash per Share |
32.16 | 44.67 | 34.41 | 33.15 | 23.19 | 39.09 | 22.23 | 15.19 | 12.85 | 12.59 |
Shareholders Equity per Share |
(14.38) | (13.30) | (12.00) | (10.56) | (11.77) | 1.09 | 29.40 | 42.22 | 48.35 | 51.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(14.38) | (13.30) | (12.00) | (10.56) | (11.77) | 1.09 | 29.40 | 42.22 | 48.35 | 51.01 |
Free Cash Flow |
5,410.00 | 5,226.00 | 3,627.00 | 4,601.00 | 3,899.00 | 3,901.00 | 3,868.00 | 3,479.00 | 3,765.00 | 4,182.00 |
Working Capital |
(9,807.00) | (6,206.00) | (4,387.00) | (3,665.00) | (2,235.00) | 1,279.00 | (402.00) | 839.00 | 451.00 | 1,336.00 |
Capital Expenditures |
(745.00) | (859.00) | (687.00) | (558.00) | (535.00) | (641.00) | (506.00) | (557.00) | (580.00) | (562.00) |
Net Current Asset Value |
(26,890.00) | (21,436.00) | (21,072.00) | (19,518.00) | (18,859.00) | (19,458.00) | (13,716.00) | (12,920.00) | (13,188.00) | (12,748.00) |
EV/EBIT |
18.45 | 20.65 | 20.11 | 13.19 | 27.57 | 0.00 | 11.17 | 31.54 | 45.00 | 5.41 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
17.22 | 19.39 | 18.28 | 11.47 | 22.88 | 0.00 | 9.81 | 26.33 | 38.16 | 4.60 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.27 | 0.25 | 0.27 | 0.28 | 0.36 | 0.44 | 0.45 | 1.19 | 1.29 | 0.52 |
Cash ROIC |
39.16% | 34.26% | 24.63% | 29.86% | 26.28% | 18.00% | 23.15% | 18.44% | 18.27% | 18.50% |
Accounts Receivable Turnover |
15.05 | 15.19 | 15.06 | 14.57 | 13.98 | 12.18 | 12.10 | 11.92 | 11.60 | 10.97 |
Accounts Payable Turnover |
6.75 | 6.75 | 6.61 | 6.56 | 6.51 | 5.94 | 6.17 | 6.14 | 6.24 | 6.28 |
Inventory Turnover |
16.48 | 15.67 | 14.51 | 13.77 | 13.22 | 12.57 | 13.10 | 12.27 | 12.48 | 12.23 |
Average Days of Payables |
56.29 | 58.41 | 58.05 | 58.67 | 55.42 | 62.92 | 61.98 | 61.00 | 59.57 | 60.47 |
Days of Inventory on Hand |
22.72 | 24.28 | 26.06 | 27.19 | 27.21 | 31.07 | 27.89 | 30.11 | 30.19 | 29.78 |
Average Receivables |
26,814.00 | 23,632.50 | 20,516.00 | 18,996.50 | 18,882.00 | 19,565.50 | 19,098.00 | 17,978.50 | 17,963.00 | 18,097.50 |
Average Payables |
57,651.50 | 51,213.50 | 44,793.50 | 40,288.00 | 38,530.50 | 38,085.00 | 35,524.00 | 33,015.00 | 31,599.50 | 29,803.50 |
Average Inventory |
23,604.00 | 22,070.00 | 20,415.00 | 19,196.50 | 18,974.00 | 17,990.00 | 16,721.50 | 16,509.50 | 15,794.00 | 15,306.50 |
Average Assets |
78,731.50 | 71,291.50 | 64,881.50 | 62,809.00 | 64,156.50 | 63,131.00 | 60,459.50 | 60,026.50 | 60,675.00 | 58,746.00 |
Average Common Equity |
(1,735.50) | (1,646.50) | (1,544.50) | (1,641.00) | (808.50) | 2,742.00 | 6,798.00 | 9,172.00 | 10,665.00 | 10,140.50 |
Columns are period end dates